BDKRB1 and glioblastoma: To evaluate radiolabelled derivatives of B1R antagonists, we focused on the involvement of B1R in glioblastoma cells and considered using two typical glioblastoma cell lines (U87MG and U251MG), which are commonly used as experimental models of glioblastoma and have been reported to express B1R [19,20,21].